DJIA 17,804.80 26.65 0.15%
NASDAQ 4,765.38 16.98 0.36%
S&P 500 2,070.65 9.42 0.46%
market minute promo

Chimerix (NASDAQ: CMRX)

40.86 2.24 (5.80%)

Quote as of


company name or ticker

Recent Quotes

CMRX $40.86 5.80%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $38.33
Previous Close $38.62
Daily Range $37.85 - $41.28
52-Week Range $13.99 - $41.28
Market Cap $1.5B
P/E Ratio -31.66
Dividend (Yield) $0.00 (0.0%)
Volume 1,453,859
Average Daily Volume 467,590
Current FY EPS -$1.78

Sector

Industry

Chimerix (CMRX) Description

Chimerix Inc is a biopharmaceutical company that develops and commercializes oral antivirals. It has two compounds in clinical development: CMX001 and CMX157. Website: http://www.chimerix.com/

News & Commentary Rss Feed

Why Chimerix, Inc. Shares Took Off

Chimerix shares rally following the close of its share offering. Find out what shareholders should have their eyes on instead.

Health Care Sector Update for 12/18/2014: CMRX,CTRV,OVAS,RWLK,NXTM

Chimerix Appoints Ronald C. Renaud, Jr. to Board of Directors

11.1% of XBI Holdings Seeing Recent Insider Buys

CMRX: Insiders Vs. Shorts

Today's Dead Cat Bounce Stock: Chimerix (CMRX)

Insiders Were Right: CMRX Makes New 52-Week High

Thinking Differently About Ebola Virus Disease: WBB Securities' Steve Brozak

Chimerix's Brincidofovir Selected For Use In Ebola Clinical Trial In West Africa By International Co

Chimerix's Brincidofovir Selected For Use In Ebola Clinical Trial In West Africa By International Consortium

Friday 11/7 Insider Buying Report: ITCI, CMRX

Chimerix's (CMRX) CEO Michelle Berrey on Q3 2014 Results - Earnings Call Transcript

See More CMRX News...